Clinical Trial Update: A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update for VERVE-102 in patients with heterozygous familial hypercholesterolemia or premature coronary artery disease; the study is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heterozygous Familial Hypercholesterolemia
• Premature Coronary Artery Disease

Drugs mentioned

• VERVE-102

Snippet

Sponsor: Verve Therapeutics, Inc. | Conditions: Heterozygous Familial Hypercholesterolemia, Premature Coronary Heart Disease | Phase 1 | Status: RECRUITING